Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants

D.A. Knight, A.C. D'Aprile, L.J. Spalding, Roy Goldie, Philip Thompson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effect of leukaemia inhibitory factor (LIF) in modulating cholinergic and sensory nerve function was examined using guinea-pig tracheal explants. Specific LIF receptors (LIFR) were immunolocalized to both cholinergic and sensory nerves. Release of SP in culture was not influenced by LIF. Similarly, maximum contraction to carbachol (C-max) was not influenced by LIF. After 3 h, maximum (E-max) eNANC-induced contraction in controls was 32 +/- 2.5% of C-max. In LIF-treated preparations, E-max was enhanced to 50 +/- 4.5% C-max (P <0.05). Cholinergic nerve-induced contractions after 3 h incubation with LIF were similar to control. After 24 h, control E-max was 25 +/- 4.5% C-max (58% smaller than E-max at 3 h). In contrast, in LIF-treated preparations, E-max was 37+2.5% C-max, (24% smaller than at 3 h, P <0.05). This did not appear to be due to the effect of LIF on muscarinic Mt receptor expression or function. Thus LIF appears to differentially influence the function of airway nerves and thus may provide an important link between the immune and neural systems.
Original languageEnglish
Pages (from-to)975-979
JournalBritish Journal of Pharmacology
Volume130
DOIs
Publication statusPublished - 2000

Fingerprint Dive into the research topics of 'Leukaemia inhibitory factor (LIF) upregulates excitatory non-adrenergic non-cholinergic and maintains cholinergic neural function in tracheal explants'. Together they form a unique fingerprint.

  • Cite this